» Articles » PMID: 26782664

How Do the Size, Charge and Shape of Nanoparticles Affect Amyloid β Aggregation on Brain Lipid Bilayer?

Overview
Journal Sci Rep
Specialty Science
Date 2016 Jan 20
PMID 26782664
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Here, we studied the effect of the size, shape, and surface charge of Au nanoparticles (AuNPs) on amyloid beta (Aβ) aggregation on a total brain lipid-based supported lipid bilayer (brain SLB), a fluid platform that facilitates Aβ-AuNP aggregation process. We found that larger AuNPs induce large and amorphous aggregates on the brain SLB, whereas smaller AuNPs induce protofibrillar Aβ structures. Positively charged AuNPs were more strongly attracted to Aβ than negatively charged AuNPs, and the stronger interactions between AuNPs and Aβ resulted in fewer β-sheets and more random coil structures. We also compared spherical AuNPs, gold nanorods (AuNRs), and gold nanocubes (AuNCs) to study the effect of nanoparticle shape on Aβ aggregation on the brain SLB. Aβ was preferentially bound to the long axis of AuNRs and fewer fibrils were formed whereas all the facets of AuNCs interacted with Aβ to produce the fibril networks. Finally, it was revealed that different nanostructures induce different cytotoxicity on neuroblastoma cells, and, overall, smaller Aβ aggregates induce higher cytotoxicity. The results offer insight into the roles of NPs and brain SLB in Aβ aggregation on the cell membrane and can facilitate the understanding of Aβ-nanostructure co-aggregation mechanism and tuning Aβ aggregate structures.

Citing Articles

Functional Nanomaterials for the Diagnosis of Alzheimer's Disease: Recent Progress and Future Perspectives.

Al Abdullah S, Najm L, Ladouceur L, Ebrahimi F, Shakeri A, Al-Jabouri N Adv Funct Mater. 2024; 33(37).

PMID: 39309539 PMC: 11415277. DOI: 10.1002/adfm.202302673.


Biosynthesis of Nanoparticles with Green Tea for Inhibition of β-Amyloid Fibrillation Coupled with Ligands Analysis.

Zhang M, Li Y, Han C, Chu S, Yu P, Cheng W Int J Nanomedicine. 2024; 19:4299-4317.

PMID: 38766654 PMC: 11102095. DOI: 10.2147/IJN.S451070.


Protective effect of trehalose sugar on amyloid-membrane interactions using BLM electrophysiology.

Xu Y, Filice C, Leonenko Z Biophys J. 2024; 123(12):1690-1704.

PMID: 38751113 PMC: 11213996. DOI: 10.1016/j.bpj.2024.05.012.


Tau- and α-synuclein-targeted gold nanoparticles: applications, opportunities, and future outlooks in the diagnosis and therapy of neurodegenerative diseases.

Tapia-Arellano A, Cabrera P, Cortes-Adasme E, Riveros A, Hassan N, Kogan M J Nanobiotechnology. 2024; 22(1):248.

PMID: 38741193 PMC: 11092257. DOI: 10.1186/s12951-024-02526-0.


Intranasal Drug Delivery by Nanotechnology: Advances in and Challenges for Alzheimer's Disease Management.

Dighe S, Jog S, Momin M, Sawarkar S, Omri A Pharmaceutics. 2024; 16(1).

PMID: 38258068 PMC: 10820353. DOI: 10.3390/pharmaceutics16010058.


References
1.
Boisselier E, Astruc D . Gold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity. Chem Soc Rev. 2009; 38(6):1759-82. DOI: 10.1039/b806051g. View

2.
Fei L, Perrett S . Effect of nanoparticles on protein folding and fibrillogenesis. Int J Mol Sci. 2009; 10(2):646-55. PMC: 2660666. DOI: 10.3390/ijms10020646. View

3.
Stefani M . Protein folding and misfolding on surfaces. Int J Mol Sci. 2009; 9(12):2515-2542. PMC: 2635651. DOI: 10.3390/ijms9122515. View

4.
Chan H, Xiao L, Yeung K, Ho S, Zhao D, Chan W . Effect of surface-functionalized nanoparticles on the elongation phase of beta-amyloid (1-40) fibrillogenesis. Biomaterials. 2012; 33(18):4443-50. DOI: 10.1016/j.biomaterials.2012.03.024. View

5.
Murphy C, Sau T, Gole A, Orendorff C, Gao J, Gou L . Anisotropic metal nanoparticles: Synthesis, assembly, and optical applications. J Phys Chem B. 2006; 109(29):13857-70. DOI: 10.1021/jp0516846. View